Undercurrent CapitalbetaSign in
1 / 1
✕
NewsThe Defiant ·

Science Raises $400 Million for Sight-Restoring Implant

The financing backs PRIMA’s European rollout and a planned US launch that still requires FDA approval....

▲ Bullish0 readers/hr

The financing backs PRIMA’s European rollout and a planned US launch that still requires FDA approval.... Read the full story at The Defiant